These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30485682)

  • 1. iTRAQ-Based Quantitative Proteomics Approach Identifies Novel Diagnostic Biomarkers That Were Essential for Glutamine Metabolism and Redox Homeostasis for Gastric Cancer.
    Jiang Z; Zhang C; Gan L; Jia Y; Xiong Y; Chen Y; Wang Z; Wang L; Luo H; Li J; Zhu R; Ji X; Yu Q; Wang L
    Proteomics Clin Appl; 2019 Jul; 13(4):e1800038. PubMed ID: 30485682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of candidate biomarkers that involved in the epigenetic transcriptional regulation for detection gastric cancer by iTRAQ based quantitative proteomic analysis.
    Jiang Z; Sun X; Zhang Q; Ji X; Yu Q; Huang T; Chen D; Chen H; Mei X; Wang L; He L; Fang J; Hou L; Wang L
    Clin Chim Acta; 2017 Aug; 471():29-37. PubMed ID: 28502558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NAD(P)-dependent steroid dehydrogenase-like protein and neutral cholesterol ester hydrolase 1 serve as novel markers for early detection of gastric cancer identified using quantitative proteomics.
    Xiao Y; Xie J; Liu L; Huang W; Han Q; Qin J; Liu S; Jiang Z
    J Clin Lab Anal; 2021 Feb; 35(2):e23652. PubMed ID: 33219617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative proteomic analysis reveals that proteins required for fatty acid metabolism may serve as diagnostic markers for gastric cancer.
    Jiang Z; Shen H; Tang B; Yu Q; Ji X; Wang L
    Clin Chim Acta; 2017 Jan; 464():148-154. PubMed ID: 27884752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gamma-Glutamylcyclotransferase: A Novel Target Molecule for Cancer Diagnosis and Treatment.
    Kageyama S; Hanada E; Ii H; Tomita K; Yoshiki T; Kawauchi A
    Biomed Res Int; 2015; 2015():345219. PubMed ID: 26339607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. γ-Glutamylcyclotransferase as a novel immunohistochemical biomarker for the malignancy of esophageal squamous tumors.
    Takemura K; Kawachi H; Eishi Y; Kitagaki K; Negi M; Kobayashi M; Uchida K; Inoue J; Inazawa J; Kawano T; Board PG
    Hum Pathol; 2014 Feb; 45(2):331-41. PubMed ID: 24342434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ornithine aminotransferase and carbamoyl phosphate synthetase 1 involved in ammonia metabolism serve as novel targets for early stages of gastric cancer.
    Jiang Z; Wei C; Luo Y; Xiao Y; Wang L; Guo W; Yuan X
    J Clin Lab Anal; 2022 Oct; 36(10):e24692. PubMed ID: 36098904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. γ-Glutamyl cyclotransferase contributes to tumor progression in high grade serous ovarian cancer by regulating epithelial-mesenchymal transition via activating PI3K/AKT/mTOR pathway.
    Li Y; Wu T; Wang Y; Yang L; Hu C; Chen L; Wu S
    Gynecol Oncol; 2018 Apr; 149(1):163-172. PubMed ID: 29429592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of GGCT inhibits cell proliferation and induces late apoptosis in human gastric cancer.
    Zhang W; Chen L; Xiang H; Hu C; Shi W; Dong P; Lv W
    BMC Biochem; 2016 Dec; 17(1):19. PubMed ID: 27905872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated expression of glutaminase confers glucose utilization via glutaminolysis in prostate cancer.
    Pan T; Gao L; Wu G; Shen G; Xie S; Wen H; Yang J; Zhou Y; Tu Z; Qian W
    Biochem Biophys Res Commun; 2015 Jan; 456(1):452-8. PubMed ID: 25482439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphoglycerate mutase 1 that is essential for glycolysis may act as a novel metabolic target for predicating poor prognosis for patients with gastric cancer.
    Wei C; Xie J; Yuan X; Luo Y; Xiao Y; Liao W; Jiang Z
    J Clin Lab Anal; 2022 Nov; 36(11):e24718. PubMed ID: 36181311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ErbB2 activation upregulates glutaminase 1 expression which promotes breast cancer cell proliferation.
    Qie S; Chu C; Li W; Wang C; Sang N
    J Cell Biochem; 2014 Mar; 115(3):498-509. PubMed ID: 24122876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting GLS1 to cancer therapy through glutamine metabolism.
    Yu W; Yang X; Zhang Q; Sun L; Yuan S; Xin Y
    Clin Transl Oncol; 2021 Nov; 23(11):2253-2268. PubMed ID: 34023970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of biomarkers for gastric cancer: a proteomics approach.
    Lin LL; Huang HC; Juan HF
    J Proteomics; 2012 Jun; 75(11):3081-97. PubMed ID: 22498886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-145 inhibits glutamine metabolism through c-myc/GLS1 pathways in ovarian cancer cells.
    Li J; Li X; Wu L; Pei M; Li H; Jiang Y
    Cell Biol Int; 2019 Aug; 43(8):921-930. PubMed ID: 31115975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of Tumor Growth Inhibition by Depletion of γ-Glutamylcyclotransferase (GGCT): A Novel Molecular Target for Anticancer Therapy.
    Kageyama S; Ii H; Taniguchi K; Kubota S; Yoshida T; Isono T; Chano T; Yoshiya T; Ito K; Yoshiki T; Kawauchi A; Nakata S
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30011933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutaminase (GLS1) gene expression in primary breast cancer.
    Vidula N; Yau C; Rugo HS
    Breast Cancer; 2023 Nov; 30(6):1079-1084. PubMed ID: 37679553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of glutaminase 1-mediated glutaminolysis improves pathological cardiac remodeling.
    Yoshikawa S; Nagao M; Toh R; Shinohara M; Iino T; Irino Y; Nishimori M; Tanaka H; Satomi-Kobayashi S; Ishida T; Hirata KI
    Am J Physiol Heart Circ Physiol; 2022 May; 322(5):H749-H761. PubMed ID: 35275762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutaminase sustains cell survival via the regulation of glycolysis and glutaminolysis in colorectal cancer.
    Song Z; Wei B; Lu C; Li P; Chen L
    Oncol Lett; 2017 Sep; 14(3):3117-3123. PubMed ID: 28928849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomics analysis of differential protein expression identifies heat shock protein 47 as a predictive marker for lymph node metastasis in patients with colorectal cancer.
    Mori K; Toiyama Y; Otake K; Fujikawa H; Saigusa S; Hiro J; Kobayashi M; Ohi M; Tanaka K; Inoue Y; Kobayashi Y; Kobayashi I; Mohri Y; Goel A; Kusunoki M
    Int J Cancer; 2017 Mar; 140(6):1425-1435. PubMed ID: 27925182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.